Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Hypersensitivity | 9 | 2019 | 845 | 1.840 |
Why?
|
| Anaphylaxis | 5 | 2021 | 707 | 0.980 |
Why?
|
| International Classification of Diseases | 3 | 2019 | 826 | 0.940 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2018 | 313 | 0.610 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2015 | 290 | 0.490 |
Why?
|
| Allergens | 2 | 2018 | 1229 | 0.460 |
Why?
|
| Allergy and Immunology | 3 | 2020 | 180 | 0.440 |
Why?
|
| Fas Ligand Protein | 6 | 2011 | 230 | 0.300 |
Why?
|
| Immunologic Tests | 2 | 2015 | 100 | 0.270 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 2256 | 0.270 |
Why?
|
| Pharmaceutical Preparations | 3 | 2019 | 952 | 0.260 |
Why?
|
| Hypersensitivity | 2 | 2021 | 963 | 0.260 |
Why?
|
| Skin Tests | 4 | 2021 | 670 | 0.240 |
Why?
|
| Aspirin | 1 | 2015 | 3142 | 0.240 |
Why?
|
| Anti-Bacterial Agents | 2 | 2018 | 6829 | 0.210 |
Why?
|
| Anemia, Hemolytic, Autoimmune | 1 | 2021 | 143 | 0.200 |
Why?
|
| Vaccines, Synthetic | 1 | 2020 | 540 | 0.180 |
Why?
|
| Neoplasms, Experimental | 1 | 2004 | 1416 | 0.180 |
Why?
|
| Urticaria | 1 | 2018 | 152 | 0.170 |
Why?
|
| Angioedema | 1 | 2018 | 179 | 0.170 |
Why?
|
| Dermatitis | 1 | 2018 | 193 | 0.160 |
Why?
|
| Viral Vaccines | 1 | 2021 | 567 | 0.150 |
Why?
|
| Denmark | 1 | 2018 | 794 | 0.150 |
Why?
|
| Eye Neoplasms | 3 | 2007 | 327 | 0.150 |
Why?
|
| Vaccines | 1 | 2021 | 600 | 0.130 |
Why?
|
| Hypersensitivity, Delayed | 1 | 2015 | 539 | 0.130 |
Why?
|
| Lymphocyte Activation | 1 | 2004 | 5989 | 0.120 |
Why?
|
| Leukemia L5178 | 3 | 2007 | 14 | 0.120 |
Why?
|
| Membrane Glycoproteins | 4 | 2005 | 3853 | 0.120 |
Why?
|
| Anesthetics, Local | 1 | 2018 | 993 | 0.110 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2004 | 4355 | 0.110 |
Why?
|
| Medical Records | 1 | 2015 | 1425 | 0.100 |
Why?
|
| Neutrophils | 3 | 2020 | 3876 | 0.100 |
Why?
|
| Apoptosis | 2 | 2004 | 10261 | 0.090 |
Why?
|
| Inpatients | 1 | 2018 | 2050 | 0.090 |
Why?
|
| Disease Management | 2 | 2015 | 2586 | 0.080 |
Why?
|
| Skin Diseases | 1 | 2015 | 1113 | 0.080 |
Why?
|
| Retinal Ganglion Cells | 1 | 2011 | 738 | 0.070 |
Why?
|
| Cytokines | 1 | 2020 | 7147 | 0.070 |
Why?
|
| Cell Membrane | 3 | 2011 | 3982 | 0.070 |
Why?
|
| Humans | 21 | 2021 | 686663 | 0.070 |
Why?
|
| Anesthesia | 1 | 2014 | 1463 | 0.070 |
Why?
|
| Glaucoma | 1 | 2011 | 909 | 0.060 |
Why?
|
| Ovalbumin | 1 | 2004 | 722 | 0.060 |
Why?
|
| Immunity, Innate | 2 | 2005 | 2892 | 0.060 |
Why?
|
| Excipients | 1 | 2021 | 85 | 0.060 |
Why?
|
| RNA, Messenger | 3 | 2021 | 13469 | 0.050 |
Why?
|
| Mice, Inbred DBA | 3 | 2007 | 724 | 0.050 |
Why?
|
| Mycophenolic Acid | 1 | 2021 | 351 | 0.050 |
Why?
|
| Female | 11 | 2021 | 375459 | 0.050 |
Why?
|
| Th1 Cells | 1 | 2004 | 1065 | 0.050 |
Why?
|
| Eye | 1 | 2002 | 726 | 0.040 |
Why?
|
| Immunoglobulins | 1 | 2021 | 901 | 0.040 |
Why?
|
| Disease Progression | 1 | 2015 | 13204 | 0.040 |
Why?
|
| Erythrocyte Transfusion | 1 | 2021 | 493 | 0.040 |
Why?
|
| Middle Aged | 5 | 2021 | 216468 | 0.040 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2020 | 803 | 0.040 |
Why?
|
| Male | 8 | 2021 | 352465 | 0.040 |
Why?
|
| Adult | 4 | 2021 | 211400 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2007 | 5391 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2015 | 7110 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2004 | 6786 | 0.030 |
Why?
|
| Paclitaxel | 1 | 2021 | 1652 | 0.030 |
Why?
|
| Boston | 2 | 2020 | 9534 | 0.030 |
Why?
|
| Neoplasms | 1 | 2021 | 19538 | 0.030 |
Why?
|
| Anterior Chamber | 2 | 2005 | 205 | 0.030 |
Why?
|
| Autoantibodies | 1 | 2021 | 1925 | 0.030 |
Why?
|
| Young Adult | 2 | 2020 | 56052 | 0.030 |
Why?
|
| Natural Language Processing | 1 | 2019 | 874 | 0.030 |
Why?
|
| United States | 2 | 2020 | 65579 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2021 | 1809 | 0.030 |
Why?
|
| United States Food and Drug Administration | 1 | 2020 | 1694 | 0.030 |
Why?
|
| Aged | 3 | 2021 | 162271 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2011 | 231 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2005 | 3793 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2021 | 4297 | 0.020 |
Why?
|
| Vaccination | 1 | 2021 | 2487 | 0.020 |
Why?
|
| Neoplasm Transplantation | 2 | 2005 | 2296 | 0.020 |
Why?
|
| Solubility | 1 | 2011 | 1192 | 0.020 |
Why?
|
| Cell Line | 1 | 2004 | 17137 | 0.020 |
Why?
|
| Mice | 5 | 2011 | 80803 | 0.020 |
Why?
|
| Injections | 1 | 2011 | 894 | 0.020 |
Why?
|
| Curriculum | 1 | 2020 | 3114 | 0.020 |
Why?
|
| Retinal Degeneration | 1 | 2011 | 407 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2011 | 2009 | 0.020 |
Why?
|
| Nerve Fibers | 1 | 2011 | 705 | 0.020 |
Why?
|
| Ligands | 2 | 2005 | 3189 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2020 | 6120 | 0.020 |
Why?
|
| Cell Death | 1 | 2011 | 1769 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 2 | 2005 | 6835 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2005 | 482 | 0.020 |
Why?
|
| Animals | 6 | 2011 | 170849 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 2777 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2019 | 3836 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2007 | 1659 | 0.020 |
Why?
|
| Chemokine CXCL2 | 1 | 2002 | 129 | 0.020 |
Why?
|
| Microglia | 1 | 2011 | 1145 | 0.020 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2002 | 177 | 0.020 |
Why?
|
| Keratitis | 1 | 2005 | 250 | 0.010 |
Why?
|
| Aqueous Humor | 1 | 2002 | 161 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2002 | 414 | 0.010 |
Why?
|
| Caspase 9 | 1 | 2002 | 204 | 0.010 |
Why?
|
| Antigens, Differentiation | 1 | 2005 | 991 | 0.010 |
Why?
|
| Caspase 8 | 1 | 2002 | 215 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 11616 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2002 | 1162 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2005 | 1577 | 0.010 |
Why?
|
| Inflammation | 3 | 2007 | 9617 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 38732 | 0.010 |
Why?
|
| Algorithms | 1 | 2019 | 13500 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 4477 | 0.010 |
Why?
|
| Caspases | 1 | 2002 | 936 | 0.010 |
Why?
|
| Transfection | 1 | 2007 | 6329 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2005 | 2103 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2002 | 1310 | 0.010 |
Why?
|
| Chemokines | 1 | 2002 | 958 | 0.010 |
Why?
|
| Protein Binding | 1 | 2011 | 9947 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 15407 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2021 | 49071 | 0.010 |
Why?
|
| Species Specificity | 1 | 2002 | 2683 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2007 | 6230 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2002 | 2913 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 16227 | 0.010 |
Why?
|
| Rabbits | 1 | 2002 | 5339 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2014 | 23739 | 0.010 |
Why?
|
| Time Factors | 1 | 2014 | 42271 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 18495 | 0.010 |
Why?
|
| Graft Survival | 1 | 2002 | 3766 | 0.010 |
Why?
|
| Macrophages | 1 | 2005 | 5748 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2005 | 4064 | 0.010 |
Why?
|
| Graft Rejection | 1 | 2002 | 4314 | 0.010 |
Why?
|
| Risk Factors | 1 | 2014 | 69278 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2011 | 24351 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2014 | 67320 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2002 | 23439 | 0.000 |
Why?
|
Concepts
(135)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(47)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_